Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDGDyskinesias, Neurologic Manifestations, PMM2-congenital disorder of glycosylation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, nervous system disorderActive, not recruitingPhase 2 / Phase 32026-08-14NCT06892288

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Glycomine, Inc.2

15 results · Page 1 of 1

Swipe the table sideways for more columns.